Skye Bioscience Book Value Per Share Growth & History (SKYE)
Skye Bioscience's book value per share was $0.60 for fiscal 2025.
View full Skye Bioscience company overviewSkye Bioscience annual book value per share history
| Fiscal year | Period ended | Book value per share | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $0.60 | -$1.60 | −72.73% |
| 2024 | 2024-12-31 | $2.20 | $2.37 | — |
| 2023 | 2023-12-31 | -$0.17 | $0.65 | — |
| 2022 | 2022-12-31 | -$0.82 | -$3.90 | — |
| 2021 | 2021-12-31 | $3.08 | $2.69 | +687.11% |
| 2020 | 2020-12-31 | $0.39 | -$0.36 | −47.78% |
| 2019 · Mar 31 | 2020-03-31 | -$2.32 | — | — |
| 2019 · Dec 31 | 2019-12-31 | $0.75 | $29.80 | — |
| 2018 | 2018-12-31 | -$29.05 | -$2.51 | — |
| 2017 | 2017-12-31 | -$26.54 | $7.25 | — |
| 2016 | 2016-12-31 | -$33.79 | -$5.46 | — |
| 2015 | 2015-12-31 | -$28.33 | -$21.24 | — |
| 2014 | 2014-12-31 | -$7.09 | -$1.23 | — |
| 2013 · Dec 31 | 2013-12-31 | -$5.86 | — | — |
| 2013 · Oct 31 | 2013-10-31 | $5.75 | $1.94 | +50.83% |
| 2012 | 2012-10-31 | $3.81 | — | — |
Skye Bioscience quarterly book value per share
| Fiscal quarter | Period ended | Book value per share | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | -$0.01 | -$1.42 | — |
| Q1 2026 | 2026-03-31 | $0.26 | -$1.66 | −86.59% |
| Q4 2025 | 2025-12-31 | $0.60 | -$1.60 | −72.73% |
| Q3 2025 | 2025-09-30 | $1.06 | -$1.44 | −57.59% |
| Q2 2025 | 2025-06-30 | $1.41 | -$1.18 | −45.67% |
| Q1 2025 | 2025-03-31 | $1.91 | -$0.90 | −31.95% |
| Q4 2024 | 2024-12-31 | $2.20 | $2.37 | — |
| Q3 2024 | 2024-09-30 | $2.50 | $2.36 | +1718.61% |
| Q2 2024 | 2024-06-30 | $2.59 | $4.60 | — |
| Q1 2024 | 2024-03-31 | $2.81 | $4.04 | — |
| Q4 2023 | 2023-12-31 | -$0.17 | $0.65 | — |
| Q3 2023 | 2023-09-30 | $0.14 | $1.79 | — |
| Q2 2023 | 2023-06-30 | -$2.00 | -$1.85 | — |
| Q1 2023 | 2023-03-31 | -$1.23 | -$2.73 | — |
| Q4 2022 | 2022-12-31 | -$0.82 | -$3.90 | — |
| Q3 2022 | 2022-09-30 | -$1.66 | -$6.00 | — |
| Q2 2022 | 2022-06-30 | -$0.15 | -$1.59 | — |
| Q1 2022 | 2022-03-31 | $1.50 | -$0.19 | −11.08% |
| Q4 2021 | 2021-12-31 | $3.08 | $2.69 | +687.11% |
| Q3 2021 | 2021-09-30 | $4.34 | $2.49 | +134.23% |
| Q2 2021 | 2021-06-30 | $1.43 | $5.66 | — |
| Q1 2021 | 2021-03-31 | $1.69 | $4.01 | — |
| Q4 2020 | 2020-12-31 | $0.39 | -$0.36 | −47.78% |
| Q2 2020 | 2020-09-30 | $1.85 | $32.43 | — |
| Q1 2020 | 2020-06-30 | -$4.22 | $17.48 | — |
| Q4 2019 · Mar 31 | 2020-03-31 | -$2.32 | $49.70 | — |
| Q4 2019 · Dec 31 | 2019-12-31 | $0.75 | $29.80 | — |
| Q3 2019 | 2019-09-30 | -$30.58 | -$11.55 | — |
| Q2 2019 | 2019-06-30 | -$21.70 | -$6.17 | — |
| Q1 2019 | 2019-03-31 | -$52.02 | -$41.16 | — |
| Q4 2018 | 2018-12-31 | -$29.05 | -$2.51 | — |
| Q3 2018 | 2018-09-30 | -$19.02 | $7.30 | — |
| Q2 2018 | 2018-06-30 | -$15.53 | $8.59 | — |
| Q1 2018 | 2018-03-31 | -$10.86 | $15.49 | — |
| Q4 2017 | 2017-12-31 | -$26.54 | $7.25 | — |
| Q3 2017 | 2017-09-30 | -$26.33 | $3.54 | — |
| Q2 2017 | 2017-06-30 | -$24.12 | -$3.84 | — |
| Q1 2017 | 2017-03-31 | -$26.36 | $3.40 | — |
| Q4 2016 | 2016-12-31 | -$33.79 | -$5.46 | — |
| Q3 2016 | 2016-09-30 | -$29.87 | $0.76 | — |
| Q2 2016 | 2016-06-30 | -$20.28 | -$7.04 | — |
| Q1 2016 | 2016-03-31 | -$29.76 | -$24.55 | — |
| Q4 2015 | 2015-12-31 | -$28.33 | -$21.24 | — |
| Q3 2015 | 2015-09-30 | -$30.63 | -$47.12 | — |
| Q2 2015 | 2015-06-30 | -$13.24 | — | — |
| Q1 2015 | 2015-03-31 | -$5.20 | — | — |
| Q4 2014 | 2014-12-31 | -$7.09 | -$1.23 | — |
| Q3 2014 | 2014-09-30 | $16.49 | — | — |
| Q2 2014 | 2014-07-31 | $5.60 | $0.46 | +8.86% |
| Q1 2014 | 2014-04-30 | $5.06 | -$0.15 | −2.82% |
| As of Jan 31, 2014 | 2014-01-31 | $6.00 | — | — |
| Q4 2013 · Dec 31 | 2013-12-31 | -$5.86 | — | — |
| Q4 2013 · Oct 31 | 2013-10-31 | $5.75 | $1.94 | +50.83% |
| Q3 2013 | 2013-07-31 | $5.14 | — | — |
| Q2 2013 | 2013-04-30 | $5.21 | — | — |
| Q4 2012 | 2012-10-31 | $3.81 | — | — |
Skye Bioscience book value per share trends
Over the last five fiscal years, Skye Bioscience's book value per share increased from $0.39 to $0.60, a change of $0.21. The latest reported quarter, Q2 2026, shows -$0.01.
What book value per share means
Book value per share estimates the common shareholders’ accounting equity represented by each share. It can help compare a company’s balance-sheet value over time, although market value can differ substantially from book value.
How book value per share is calculated
TickerStat calculates book value per share as SEC-reported common shareholders’ equity divided by reported period-end common shares. Preferred equity is subtracted when separately reported, and basic weighted-average shares are used only when period-end shares are unavailable. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Skye Bioscience source filings ↗